BIO INX and Rousselot Announce Collaboration on Materials for 3D Bioprinting

ZWIJNAARDE, Belgium - March 13, 2024 - PRLog -- In a significant leap forward for the field of 3D bioprinting, BIO INX, a leading material developer for 3D bioprinting, proudly announces the strategic collaboration with Rousselot, a global leader in gelatin- and collagen-based solutions This collaboration underscores BIO INX' and Rousselot's commitment to bring 3D bioprinting technologies closer to the clinic.

As part of this collaboration, BIO INX is set to distribute Rousselot's research and technical grade X-Pure^® gelatin biomaterials, renowned for their quality and reliability. The X-Pure gelatin range will be seamlessly integrated into BIO INX' offerings, making these cutting-edge materials accessible to researchers and academics worldwide through the webshop of BIO INX.

The partnership extends beyond mere distribution, as BIO INX introduces an innovative product, the X-Pure version of their renowned extrusion bioink, GEL-MA INX^©. This pioneering bioink, produced in collaboration with Rousselot, is the first step towards a GMP-like gelatin-based bioink which enables to print constructs in the presence of living cells in a straightforward manner. The development is in line with the mission of BIO INX^® to make bioprinting turnkey. It represents a significant stride towards bringing the technology of 3D bioprinting closer to the clinic by enhancing reproducibility and standardization while adhering to the elevated quality requirements.

Contact:

Jasper Van Hoorick,

CEO, BIO INX

E : Jasper.vanhoorick@bioinx.com

T : +32 499 16 98 94

www.bioinx.com

Contact: Caroline Brochard-Garnier

Director Communications & PR, Rousselot
E: Caroline.brochard-garnier@rousselot.com